Compliance to clinical pathways in the management of suspected pulmonary embolus: are there cost implications?
- 11 April 2017
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 47 (4) , 458-461
Abstract
This study investigated the cost implications of poor compliance to established guidelines for management of suspected pulmonary embolism (PE) in two NSW public hospitals. A retrospective audit showed that the prevalence of PE overall was 9.9% (4.3% in the low-risk groups) in 436 patients. An estimated total of $32 454 (14%) was spent on unnecessary tests.Keywords
This publication has 18 references indexed in Scilit:
- Changing trends in venous thromboembolism‐related imaging in Western Australian teaching hospitals, 2002–2010Medical Journal of Australia, 2013
- Implementation of a clinical prediction tool for pulmonary embolism diagnosis in a tertiary teaching hospital reduces the number of computed tomography pulmonary angiograms performedInternal Medicine Journal, 2012
- Inappropriate Use of D-Dimer Assay and Pulmonary CT Angiography in the Evaluation of Suspected Acute Pulmonary EmbolismAmerican Journal of Medical Quality, 2011
- Study of compliance with a clinical pathway for suspected pulmonary embolismInternal Medicine Journal, 2011
- Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysisBMJ, 2009
- Prediction of Pulmonary Embolism in the Emergency Department: The Revised Geneva ScoreAnnals of Internal Medicine, 2006
- Effectiveness of Managing Suspected Pulmonary Embolism Using an Algorithm Combining Clinical Probability, D-Dimer Testing, and Computed TomographyJAMA, 2006
- Exclusion of venous thromboembolism: evaluation of D-Dimer PLUS for the quantitative determination of D-dimerThrombosis Research, 2005
- State-of-the-Art-Review : Exclusion and Diagnosis of Pulmonary Embolism by a Rapid ELISA D-dimer Test and Noninvasive Imaging Techniques within the Context of a Clinical ModelClinical and Applied Thrombosis/Hemostasis, 2000
- Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysisHealth Economics, 1994